Cardio Diagnostics Holdings, Inc. Shareholders' Equity
Cardio Diagnostics Holdings, Inc. (CDIO) had Shareholders' Equity of $7.43 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $7.43M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $8.90M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $6.97M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $8.15M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $7.43M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $8.90M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $6.97M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $8.15M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $9.72M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $11.38M 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $9.56M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $3.69M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $3.07M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $3.04M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $2.96M 10-K · filed 2026-03-13 | |
| 2023-09-30 | $2.29M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $2.91M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $3.42M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $4.30M 10-K · filed 2025-03-20 | |
| 2022-09-30 | $9.57M 10-Q · filed 2023-11-13 | -$353.70K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $9.70M 10-Q · filed 2023-11-13 | -$32.58K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $778.05K 10-Q · filed 2023-11-13 | $460.07K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.07M 10-K · filed 2024-04-01 | $682.73K 10-K · filed 2022-03-31 |
| 2021-09-30 | $24.28K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $24.60K 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $60.37K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |